The ground-breaking drug, Keytruda also known as Pembrolizumab has been found to cut the risk of triple-negative breast cancer reoccurring by 37%. The drug utilizes the patient’s own immune system to fight cancer. Pembrolizumab helps the immune system to be on the alert for cancer cells and destroy them. It is already being used to … Read more
A recent study conducted in Israel at Maccabi Healthcare and Tel Aviv University compared the outcomes of over 76,000 Israelis in three groups. Those people who had Covid-19 but weren’t vaccinated against an equal number of people who had been fully vaccinated but hadn’t been previously infected and those previously COVID infected with only a … Read more
The Coronavirus Delta variant is proving to be one of the most difficult challenges and is prolonging the pandemic. This highly contagious strain of the virus has spread swiftly among those that are unvaccinated but is also infecting those that have had both their inoculations. A new study published in the journal The Lancet Infectious … Read more
Professor Dan Peer, a cancer expert from Tel Aviv University has spoken to the Times of Israel regarding a new way to treat cancer in mice that is so precise, it’s like using “tiny scissors” to target the cells. ‘This is the first study in the world to prove that the CRISPR genome editing system, … Read more